Meralgia paresthetica after liver transplantation: a case report

Meralgia Paresthetica

PURPOSE OF REVIEW

This review article summaries the epidemiology, etiology, clinical presentations, and latest treatment modalities of meralgia paresthetica, including the latest data about peripheral and spinal cord stimulation therapy. Meralgia paresthetica (MP) causes burning, stinging, or numbness in the anterolateral part of the thigh, usually due to compression of the lateral femoral cutaneous nerve (LFCN).

RECENT FINDINGS

There are emerging data regarding the benefit of interventional pain procedures, including steroid injection and radiofrequency ablation, and other interventions including spinal cord and peripheral nerve stimulation reserved for refractory cases. The strength of evidence for treatment choices in meralgia paraesthetica is weak. Some observational studies are comparing local injection of corticosteroid versus surgical interventions. However, more extensive studies are needed regarding the long-term benefit of peripheral and spinal cord stimulation therapy.

Beneath the Surface: Massive Retroperitoneal Liposarcoma Masquerading as Meralgia Paresthetica

In patients presenting with focal neurologic findings involving the lower extremities, a thorough abdominal examination should be considered an integral part of the full neurologic work up.

Relationships of the lateral femoral cutaneous nerve to bony landmarks

BACKGROUND

The lateral femoral cutaneous nerve (LFCN) can be at risk during, for example, the insertion of pins in the anterior superior iliac spine (ASIS) during external fixation of the pelvis, total hip arthroplasty through a direct anterior approach, open surgery for impingement in the hip through an anterior approach, and periacetabular osteotomy. During surgery, the surgeon usually assumes the location of the LFCN by using the ASIS as a landmark.

QUESTIONS/PURPOSES

We investigated (1) whether there is any relationship between the LFCN and the ASIS and (2) the anatomy of the LFCN at the lateral border of the psoas major.

METHODS

Using 25 formalin-fixed cadavers, we determined the location of the LFCN emergence point as above, same level with, or below the iliac crest (IC). We measured the distances between the LFCN emergence point and the crossing of the IC and psoas major, ASIS, and pubic tubercle. We measured the distances between the ASIS and pubic tubercle (AB) and the ASIS and the point where the LFCN crossed the inguinal ligament (AC) and then calculated AC/AB.

RESULTS

The LFCN was below the IC on 19 sides, at the same level on 13 sides, and above on 12 sides. The distances were -0.98 ± 5.57 cm to the IC, 12.39 ± 2.67 cm to the ASIS, and 17.76 ± 3.33 cm to the pubic tubercle. AB was 13.11 ± 1.08 cm, AC 2.95 ± 2.01 cm, and AC/AB 0.22 ± 0.16.

CONCLUSIONS/CLINICAL RELEVANCE

The LFCN may emerge from the lateral border of the psoas major above or below the IC. The AC/AB ratio can help surgeons to find the LFCN in patients with different body types.